This suggests that treatment with CPAP/PAP reduces the hypoxic burden associated with sleep apnea, thereby reducing fibrinolysis, blood coagulation, plasminogen activation, and inflammatory responses. The gene discussed is PLG; the disease is Sleep apnea.